Psychotherapeutic Drug Spending Surged From 1997 to 2004

[Guest guest]

http://www.medscape.com/viewarticle/555384?src=mp

Psychotherapeutic Drug Spending Surged From 1997 to 2004

Agency for Healthcare Research and Quality (AHRQ)

Medscape Business of Medicine. 2007; ©2007 Medscape

Posted 05/07/2007

The information in this article is from HCUPnet, an online query system that

provides access to health statistics and information on hospital stays from the

Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for

Healthcare Research and Quality (AHRQ). This project includes the largest set of

publicly available databases on all patients in the United States, regardless of

type of insurance or whether the patients had insurance. To access HCUPnet, go

to http://hcup.ahrq.gov/HCUPnet.asp.

Spending on prescription drugs to treat depression, anxiety, pain,

schizophrenia, and other conditions climbed from $7.9 billion in 1997 to $20

billion in 2004 -- over a 150% increase, according to the latest News and

Numbers from the Agency for Healthcare Research and Quality.

a.. The sharpest increase was for antipsychotic agents, medications used

to manage schizophrenia, bipolar disorder, and other psychoses. They saw an

increase from $1.3 billion to $4.1 billion from 1997 to 2004.

b.. Spending for central nervous system stimulants to treat pain and

control seizures nearly tripled over the same time period, increasing from $0.6

billion to $1.7 billion.

c.. Spending on antidepressants more than doubled from 1997 to 2004,

increasing from $5.1 billion to $12.1 billion, as did expenditures for

anxiolytics, sedatives, and hypnotics for anxiety and sleep disorders. Spending

for these drugs rose from $.9 billion to $2.1 billion.

d.. During the same time period, overall prescriptions for

psychotherapeutic drugs increased from 141.9 million to 244.3 million; the

number of people prescribed at least one such drug rose from 21 million to 32.6

million; and the average price per purchase increased from $55.80 to $82.00.

AHRQ, a part of the US Department of Health and Human Services, works to improve

the quality, safety, efficiency, and effectiveness of healthcare in the United

States. The data in this AHRQ News and Numbers come from the Agency's Medical

Expenditure Panel Survey, a highly detailed source of information on the health

services that Americans use, how frequently they use them, the cost of these

services, and how they are paid.

For more information on this AHRQ News and Numbers, see Trends in the Use and

Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and

All Subclasses, 1997 and 2004.

Agency for Healthcare Research and Quality (AHRQ), Rockville, land;

http://hcup.ahrq.gov/HCUPnet.asp

[Guest guest]

http://www.medscape.com/viewarticle/555384?src=mp

Psychotherapeutic Drug Spending Surged From 1997 to 2004

Agency for Healthcare Research and Quality (AHRQ)

Medscape Business of Medicine. 2007; ©2007 Medscape

Posted 05/07/2007

The information in this article is from HCUPnet, an online query system that

provides access to health statistics and information on hospital stays from the

Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for

Healthcare Research and Quality (AHRQ). This project includes the largest set of

publicly available databases on all patients in the United States, regardless of

type of insurance or whether the patients had insurance. To access HCUPnet, go

to http://hcup.ahrq.gov/HCUPnet.asp.

Spending on prescription drugs to treat depression, anxiety, pain,

schizophrenia, and other conditions climbed from $7.9 billion in 1997 to $20

billion in 2004 -- over a 150% increase, according to the latest News and

Numbers from the Agency for Healthcare Research and Quality.

a.. The sharpest increase was for antipsychotic agents, medications used

to manage schizophrenia, bipolar disorder, and other psychoses. They saw an

increase from $1.3 billion to $4.1 billion from 1997 to 2004.

b.. Spending for central nervous system stimulants to treat pain and

control seizures nearly tripled over the same time period, increasing from $0.6

billion to $1.7 billion.

c.. Spending on antidepressants more than doubled from 1997 to 2004,

increasing from $5.1 billion to $12.1 billion, as did expenditures for

anxiolytics, sedatives, and hypnotics for anxiety and sleep disorders. Spending

for these drugs rose from $.9 billion to $2.1 billion.

d.. During the same time period, overall prescriptions for

psychotherapeutic drugs increased from 141.9 million to 244.3 million; the

number of people prescribed at least one such drug rose from 21 million to 32.6

million; and the average price per purchase increased from $55.80 to $82.00.

AHRQ, a part of the US Department of Health and Human Services, works to improve

the quality, safety, efficiency, and effectiveness of healthcare in the United

States. The data in this AHRQ News and Numbers come from the Agency's Medical

Expenditure Panel Survey, a highly detailed source of information on the health

services that Americans use, how frequently they use them, the cost of these

services, and how they are paid.

For more information on this AHRQ News and Numbers, see Trends in the Use and

Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and

All Subclasses, 1997 and 2004.

Agency for Healthcare Research and Quality (AHRQ), Rockville, land;

http://hcup.ahrq.gov/HCUPnet.asp

[Guest guest]

http://www.medscape.com/viewarticle/555384?src=mp

Psychotherapeutic Drug Spending Surged From 1997 to 2004

Agency for Healthcare Research and Quality (AHRQ)

Medscape Business of Medicine. 2007; ©2007 Medscape

Posted 05/07/2007

The information in this article is from HCUPnet, an online query system that

provides access to health statistics and information on hospital stays from the

Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for

Healthcare Research and Quality (AHRQ). This project includes the largest set of

publicly available databases on all patients in the United States, regardless of

type of insurance or whether the patients had insurance. To access HCUPnet, go

to http://hcup.ahrq.gov/HCUPnet.asp.

Spending on prescription drugs to treat depression, anxiety, pain,

schizophrenia, and other conditions climbed from $7.9 billion in 1997 to $20

billion in 2004 -- over a 150% increase, according to the latest News and

Numbers from the Agency for Healthcare Research and Quality.

a.. The sharpest increase was for antipsychotic agents, medications used

to manage schizophrenia, bipolar disorder, and other psychoses. They saw an

increase from $1.3 billion to $4.1 billion from 1997 to 2004.

b.. Spending for central nervous system stimulants to treat pain and

control seizures nearly tripled over the same time period, increasing from $0.6

billion to $1.7 billion.

c.. Spending on antidepressants more than doubled from 1997 to 2004,

increasing from $5.1 billion to $12.1 billion, as did expenditures for

anxiolytics, sedatives, and hypnotics for anxiety and sleep disorders. Spending

for these drugs rose from $.9 billion to $2.1 billion.

d.. During the same time period, overall prescriptions for

psychotherapeutic drugs increased from 141.9 million to 244.3 million; the

number of people prescribed at least one such drug rose from 21 million to 32.6

million; and the average price per purchase increased from $55.80 to $82.00.

AHRQ, a part of the US Department of Health and Human Services, works to improve

the quality, safety, efficiency, and effectiveness of healthcare in the United

States. The data in this AHRQ News and Numbers come from the Agency's Medical

Expenditure Panel Survey, a highly detailed source of information on the health

services that Americans use, how frequently they use them, the cost of these

services, and how they are paid.

For more information on this AHRQ News and Numbers, see Trends in the Use and

Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and

All Subclasses, 1997 and 2004.

Agency for Healthcare Research and Quality (AHRQ), Rockville, land;

http://hcup.ahrq.gov/HCUPnet.asp

[Guest guest]

http://www.medscape.com/viewarticle/555384?src=mp

Psychotherapeutic Drug Spending Surged From 1997 to 2004

Agency for Healthcare Research and Quality (AHRQ)

Medscape Business of Medicine. 2007; ©2007 Medscape

Posted 05/07/2007

The information in this article is from HCUPnet, an online query system that

provides access to health statistics and information on hospital stays from the

Healthcare Cost and Utilization Project (HCUP) sponsored by the Agency for

Healthcare Research and Quality (AHRQ). This project includes the largest set of

publicly available databases on all patients in the United States, regardless of

type of insurance or whether the patients had insurance. To access HCUPnet, go

to http://hcup.ahrq.gov/HCUPnet.asp.

Spending on prescription drugs to treat depression, anxiety, pain,

schizophrenia, and other conditions climbed from $7.9 billion in 1997 to $20

billion in 2004 -- over a 150% increase, according to the latest News and

Numbers from the Agency for Healthcare Research and Quality.

a.. The sharpest increase was for antipsychotic agents, medications used

to manage schizophrenia, bipolar disorder, and other psychoses. They saw an

increase from $1.3 billion to $4.1 billion from 1997 to 2004.

b.. Spending for central nervous system stimulants to treat pain and

control seizures nearly tripled over the same time period, increasing from $0.6

billion to $1.7 billion.

c.. Spending on antidepressants more than doubled from 1997 to 2004,

increasing from $5.1 billion to $12.1 billion, as did expenditures for

anxiolytics, sedatives, and hypnotics for anxiety and sleep disorders. Spending

for these drugs rose from $.9 billion to $2.1 billion.

d.. During the same time period, overall prescriptions for

psychotherapeutic drugs increased from 141.9 million to 244.3 million; the

number of people prescribed at least one such drug rose from 21 million to 32.6

million; and the average price per purchase increased from $55.80 to $82.00.

AHRQ, a part of the US Department of Health and Human Services, works to improve

the quality, safety, efficiency, and effectiveness of healthcare in the United

States. The data in this AHRQ News and Numbers come from the Agency's Medical

Expenditure Panel Survey, a highly detailed source of information on the health

services that Americans use, how frequently they use them, the cost of these

services, and how they are paid.

For more information on this AHRQ News and Numbers, see Trends in the Use and

Expenditures for the Therapeutic Class Prescribed Psychotherapeutic Agents and

All Subclasses, 1997 and 2004.

Agency for Healthcare Research and Quality (AHRQ), Rockville, land;

http://hcup.ahrq.gov/HCUPnet.asp

[Guest guest]

Couple this data with the multi-millions of $ given by

pharma lobby to campaigns & millions given to FDA docs

to evaluate safety & efficacy of drugs. Do any of you

wonder why the system is broken?

--- SSRI medications

<mofunnow@...> wrote:

>

> http://www.medscape.com/viewarticle/555384?src=mp

>

> Psychotherapeutic Drug Spending Surged From 1997 to

2004

>

>

> Agency for Healthcare Research and Quality (AHRQ)

>

> Medscape Business of Medicine. 2007; ©2007 Medscape

> Posted 05/07/2007

>

> The information in this article is from HCUPnet, an

online query system tha

> t provides access to health statistics and

information on hospital stays fr

> om the Healthcare Cost and Utilization Project

(HCUP) sponsored by the Agen

> cy for Healthcare Research and Quality (AHRQ). This

project includes the la

> rgest set of publicly available databases on all

patients in the United Sta

> tes, regardless of type of insurance or whether the

patients had insurance.

> To access HCUPnet, go to

http://hcup.ahrq.gov/HCUPnet.asp.

>

> Spending on prescription drugs to treat depression,

anxiety, pain, schizoph

> renia, and other conditions climbed from $7.9

billion in 1997 to $20 billio

> n in 2004 -- over a 150% increase, according to the

latest News and Numbers

> from the Agency for Healthcare Research and

Quality.

>

> a.. The sharpest increase was for

antipsychotic agents, medications

> used to manage schizophrenia, bipolar disorder, and

other psychoses. They

> saw an increase from $1.3 billion to $4.1 billion

from 1997 to 2004.

>

>

> b.. Spending for central nervous system

stimulants to treat pain an

> d control seizures nearly tripled over the same time

period, increasing fro

> m $0.6 billion to $1.7 billion.

>

>

> c.. Spending on antidepressants more than

doubled from 1997 to 2004

> , increasing from $5.1 billion to $12.1 billion, as

did expenditures for an

> xiolytics, sedatives, and hypnotics for anxiety and

sleep disorders. Spendi

> ng for these drugs rose from $.9 billion to $2.1

billion.

>

>

> d.. During the same time period, overall

prescriptions for psychoth

> erapeutic drugs increased from 141.9 million to

244.3 million; the number o

> f people prescribed at least one such drug rose from

21 million to 32.6 mil

> lion; and the average price per purchase increased

from $55.80 to $82.00.

>

>

> AHRQ, a part of the US Department of Health and

Human Services, works to im

> prove the quality, safety, efficiency, and

effectiveness of healthcare in t

> he United States. The data in this AHRQ News and

Numbers come from the Agen

> cy's Medical Expenditure Panel Survey, a highly

detailed source of informat

> ion on the health services that Americans use, how

frequently they use them

> , the cost of these services, and how they are paid.

>

> For more information on this AHRQ News and Numbers,

see Trends in the Use a

> nd Expenditures for the Therapeutic Class Prescribed

Psychotherapeutic Agen

> ts and All Subclasses, 1997 and 2004.

>

>

>

> Agency for Healthcare Research and Quality (AHRQ),

Rockville, land; htt

> p://hcup.ahrq.gov/HCUPnet.asp

>

> [Non-text portions of this message have been

removed]

>

FAIR USE NOTICE: This may contain copyrighted material. Such material is made

available for educational purposes, to advance understanding of human rights,

democracy, scientific, moral, ethical, and social justice issues, etc. This

transmittal constitutes a 'fair use' of any such copyrighted material as

provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This

material is distributed without profit.

________________________________________________________________________________\

____Be a better Heartthrob. Get better relationship answers from someone who

knows. Answers - Check it out.

http://answers./dir/?link=list & sid=396545433

[Guest guest]

Couple this data with the multi-millions of $ given by

pharma lobby to campaigns & millions given to FDA docs

to evaluate safety & efficacy of drugs. Do any of you

wonder why the system is broken?

--- SSRI medications

<mofunnow@...> wrote:

>

> http://www.medscape.com/viewarticle/555384?src=mp

>

> Psychotherapeutic Drug Spending Surged From 1997 to

2004

>

>

> Agency for Healthcare Research and Quality (AHRQ)

>

> Medscape Business of Medicine. 2007; ©2007 Medscape

> Posted 05/07/2007

>

> The information in this article is from HCUPnet, an

online query system tha

> t provides access to health statistics and

information on hospital stays fr

> om the Healthcare Cost and Utilization Project

(HCUP) sponsored by the Agen

> cy for Healthcare Research and Quality (AHRQ). This

project includes the la

> rgest set of publicly available databases on all

patients in the United Sta

> tes, regardless of type of insurance or whether the

patients had insurance.

> To access HCUPnet, go to

http://hcup.ahrq.gov/HCUPnet.asp.

>

> Spending on prescription drugs to treat depression,

anxiety, pain, schizoph

> renia, and other conditions climbed from $7.9

billion in 1997 to $20 billio

> n in 2004 -- over a 150% increase, according to the

latest News and Numbers

> from the Agency for Healthcare Research and

Quality.

>

> a.. The sharpest increase was for

antipsychotic agents, medications

> used to manage schizophrenia, bipolar disorder, and

other psychoses. They

> saw an increase from $1.3 billion to $4.1 billion

from 1997 to 2004.

>

>

> b.. Spending for central nervous system

stimulants to treat pain an

> d control seizures nearly tripled over the same time

period, increasing fro

> m $0.6 billion to $1.7 billion.

>

>

> c.. Spending on antidepressants more than

doubled from 1997 to 2004

> , increasing from $5.1 billion to $12.1 billion, as

did expenditures for an

> xiolytics, sedatives, and hypnotics for anxiety and

sleep disorders. Spendi

> ng for these drugs rose from $.9 billion to $2.1

billion.

>

>

> d.. During the same time period, overall

prescriptions for psychoth

> erapeutic drugs increased from 141.9 million to

244.3 million; the number o

> f people prescribed at least one such drug rose from

21 million to 32.6 mil

> lion; and the average price per purchase increased

from $55.80 to $82.00.

>

>

> AHRQ, a part of the US Department of Health and

Human Services, works to im

> prove the quality, safety, efficiency, and

effectiveness of healthcare in t

> he United States. The data in this AHRQ News and

Numbers come from the Agen

> cy's Medical Expenditure Panel Survey, a highly

detailed source of informat

> ion on the health services that Americans use, how

frequently they use them

> , the cost of these services, and how they are paid.

>

> For more information on this AHRQ News and Numbers,

see Trends in the Use a

> nd Expenditures for the Therapeutic Class Prescribed

Psychotherapeutic Agen

> ts and All Subclasses, 1997 and 2004.

>

>

>

> Agency for Healthcare Research and Quality (AHRQ),

Rockville, land; htt

> p://hcup.ahrq.gov/HCUPnet.asp

>

> [Non-text portions of this message have been

removed]

>

FAIR USE NOTICE: This may contain copyrighted material. Such material is made

available for educational purposes, to advance understanding of human rights,

democracy, scientific, moral, ethical, and social justice issues, etc. This

transmittal constitutes a 'fair use' of any such copyrighted material as

provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This

material is distributed without profit.

________________________________________________________________________________\

____Be a better Heartthrob. Get better relationship answers from someone who

knows. Answers - Check it out.

http://answers./dir/?link=list & sid=396545433

[Guest guest]

Couple this data with the multi-millions of $ given by

pharma lobby to campaigns & millions given to FDA docs

to evaluate safety & efficacy of drugs. Do any of you

wonder why the system is broken?

--- SSRI medications

<mofunnow@...> wrote:

>

> http://www.medscape.com/viewarticle/555384?src=mp

>

> Psychotherapeutic Drug Spending Surged From 1997 to

2004

>

>

> Agency for Healthcare Research and Quality (AHRQ)

>

> Medscape Business of Medicine. 2007; ©2007 Medscape

> Posted 05/07/2007

>

> The information in this article is from HCUPnet, an

online query system tha

> t provides access to health statistics and

information on hospital stays fr

> om the Healthcare Cost and Utilization Project

(HCUP) sponsored by the Agen

> cy for Healthcare Research and Quality (AHRQ). This

project includes the la

> rgest set of publicly available databases on all

patients in the United Sta

> tes, regardless of type of insurance or whether the

patients had insurance.

> To access HCUPnet, go to

http://hcup.ahrq.gov/HCUPnet.asp.

>

> Spending on prescription drugs to treat depression,

anxiety, pain, schizoph

> renia, and other conditions climbed from $7.9

billion in 1997 to $20 billio

> n in 2004 -- over a 150% increase, according to the

latest News and Numbers

> from the Agency for Healthcare Research and

Quality.

>

> a.. The sharpest increase was for

antipsychotic agents, medications

> used to manage schizophrenia, bipolar disorder, and

other psychoses. They

> saw an increase from $1.3 billion to $4.1 billion

from 1997 to 2004.

>

>

> b.. Spending for central nervous system

stimulants to treat pain an

> d control seizures nearly tripled over the same time

period, increasing fro

> m $0.6 billion to $1.7 billion.

>

>

> c.. Spending on antidepressants more than

doubled from 1997 to 2004

> , increasing from $5.1 billion to $12.1 billion, as

did expenditures for an

> xiolytics, sedatives, and hypnotics for anxiety and

sleep disorders. Spendi

> ng for these drugs rose from $.9 billion to $2.1

billion.

>

>

> d.. During the same time period, overall

prescriptions for psychoth

> erapeutic drugs increased from 141.9 million to

244.3 million; the number o

> f people prescribed at least one such drug rose from

21 million to 32.6 mil

> lion; and the average price per purchase increased

from $55.80 to $82.00.

>

>

> AHRQ, a part of the US Department of Health and

Human Services, works to im

> prove the quality, safety, efficiency, and

effectiveness of healthcare in t

> he United States. The data in this AHRQ News and

Numbers come from the Agen

> cy's Medical Expenditure Panel Survey, a highly

detailed source of informat

> ion on the health services that Americans use, how

frequently they use them

> , the cost of these services, and how they are paid.

>

> For more information on this AHRQ News and Numbers,

see Trends in the Use a

> nd Expenditures for the Therapeutic Class Prescribed

Psychotherapeutic Agen

> ts and All Subclasses, 1997 and 2004.

>

>

>

> Agency for Healthcare Research and Quality (AHRQ),

Rockville, land; htt

> p://hcup.ahrq.gov/HCUPnet.asp

>

> [Non-text portions of this message have been

removed]

>

FAIR USE NOTICE: This may contain copyrighted material. Such material is made

available for educational purposes, to advance understanding of human rights,

democracy, scientific, moral, ethical, and social justice issues, etc. This

transmittal constitutes a 'fair use' of any such copyrighted material as

provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This

material is distributed without profit.

________________________________________________________________________________\

____Be a better Heartthrob. Get better relationship answers from someone who

knows. Answers - Check it out.

http://answers./dir/?link=list & sid=396545433

[Guest guest]

Couple this data with the multi-millions of $ given by

pharma lobby to campaigns & millions given to FDA docs

to evaluate safety & efficacy of drugs. Do any of you

wonder why the system is broken?

--- SSRI medications

<mofunnow@...> wrote:

>

> http://www.medscape.com/viewarticle/555384?src=mp

>

> Psychotherapeutic Drug Spending Surged From 1997 to

2004

>

>

> Agency for Healthcare Research and Quality (AHRQ)

>

> Medscape Business of Medicine. 2007; ©2007 Medscape

> Posted 05/07/2007

>

> The information in this article is from HCUPnet, an

online query system tha

> t provides access to health statistics and

information on hospital stays fr

> om the Healthcare Cost and Utilization Project

(HCUP) sponsored by the Agen

> cy for Healthcare Research and Quality (AHRQ). This

project includes the la

> rgest set of publicly available databases on all

patients in the United Sta

> tes, regardless of type of insurance or whether the

patients had insurance.

> To access HCUPnet, go to

http://hcup.ahrq.gov/HCUPnet.asp.

>

> Spending on prescription drugs to treat depression,

anxiety, pain, schizoph

> renia, and other conditions climbed from $7.9

billion in 1997 to $20 billio

> n in 2004 -- over a 150% increase, according to the

latest News and Numbers

> from the Agency for Healthcare Research and

Quality.

>

> a.. The sharpest increase was for

antipsychotic agents, medications

> used to manage schizophrenia, bipolar disorder, and

other psychoses. They

> saw an increase from $1.3 billion to $4.1 billion

from 1997 to 2004.

>

>

> b.. Spending for central nervous system

stimulants to treat pain an

> d control seizures nearly tripled over the same time

period, increasing fro

> m $0.6 billion to $1.7 billion.

>

>

> c.. Spending on antidepressants more than

doubled from 1997 to 2004

> , increasing from $5.1 billion to $12.1 billion, as

did expenditures for an

> xiolytics, sedatives, and hypnotics for anxiety and

sleep disorders. Spendi

> ng for these drugs rose from $.9 billion to $2.1

billion.

>

>

> d.. During the same time period, overall

prescriptions for psychoth

> erapeutic drugs increased from 141.9 million to

244.3 million; the number o

> f people prescribed at least one such drug rose from

21 million to 32.6 mil

> lion; and the average price per purchase increased

from $55.80 to $82.00.

>

>

> AHRQ, a part of the US Department of Health and

Human Services, works to im

> prove the quality, safety, efficiency, and

effectiveness of healthcare in t

> he United States. The data in this AHRQ News and

Numbers come from the Agen

> cy's Medical Expenditure Panel Survey, a highly

detailed source of informat

> ion on the health services that Americans use, how

frequently they use them

> , the cost of these services, and how they are paid.

>

> For more information on this AHRQ News and Numbers,

see Trends in the Use a

> nd Expenditures for the Therapeutic Class Prescribed

Psychotherapeutic Agen

> ts and All Subclasses, 1997 and 2004.

>

>

>

> Agency for Healthcare Research and Quality (AHRQ),

Rockville, land; htt

> p://hcup.ahrq.gov/HCUPnet.asp

>

> [Non-text portions of this message have been

removed]

>

FAIR USE NOTICE: This may contain copyrighted material. Such material is made

available for educational purposes, to advance understanding of human rights,

democracy, scientific, moral, ethical, and social justice issues, etc. This

transmittal constitutes a 'fair use' of any such copyrighted material as

provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This

material is distributed without profit.

________________________________________________________________________________\

____Be a better Heartthrob. Get better relationship answers from someone who

knows. Answers - Check it out.

http://answers./dir/?link=list & sid=396545433